The regulatory status of curcumin products warrants commensurate attention
Retatrutide's own published trials, the Phase 2 study in the New England Journal of Medicine and the Phase 3 TRIUMPH-1 results released in May 2026, did not list hair loss or alopecia among the reported side effects
Particularly effective for flexible tissues (tendons, ligaments, muscle) versus rigid mineralized bone
doi: 10.1136/jmg.34.12.1007
1c,d) and was previously suggested as a candidate for a potential activator site, first, because its positive charge might stabilize or bind GSH as GS , and, second, because of its evolutionary conserved position that is equivalent to the GSH-interacting catalytic residue of glutathione transferases 3
"And number two, from a dermatologist's perspective, it's worrisome what it does to moles and the potential for melanoma." Dr Goodman says Melanotan II can change the appearance and shape of moles, making melanoma harder to detect